Investor Contact
Media & Investor Relations:
Troy Wichterman
Chief Financial Officer
(425) 402 - 1400
twichterman@biolifesolutions.com
Transfer Agent
Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, New York 11717
USA
(877) 830 - 4936
shareholder@broadridge.com
Investor Alerts
Register here to receive email notifications with updates about our press releases, stock price, SEC filings and more.
Financials
NASDAQBLFS
| Beta | 1.87 |
|---|---|
| Shares Outstanding | 46.1M |
| Average Volume (10 days) | 232.3K |
| Qtrly Dividend (Ann. Yield) | -- (--) |
Analyst Views
| Current Mean Recommendation | Strong Buy |
|---|
| Strong Buy | 10 | |
|---|---|---|
| Buy | 0 | |
| Hold | 0 | |
| Underperform | 0 | |
| Sell | 0 |
Recent Insider Transactions
Mathew Aby EVP & Chief Scientific Officer | (10,000) Sell Sep 19, 2024 |
|---|---|
Mathew Aby EVP & Chief Scientific Officer | (10,000) Sell Sep 18, 2024 |
Richardson Garrie | (3,070) Sell Sep 16, 2024 |
Mathew Aby EVP & Chief Scientific Officer | (343) Sell Sep 16, 2024 |
Foster Karen Chief Quality Officer | (267) Sell Sep 16, 2024 |